Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.215 CAD | +13.16% | +19.44% | +22.86% |
12/06 | Theralase Technologies Inc. Announces Rutherrin Increases Efficacy of Chemotherapy | CI |
10/06 | Theralase Technologies Inc. Announces Ruvidar Enhances Efficacy of Cancer Drug | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.86% | 3.76Cr | |
-0.72% | 84Cr | |
-30.42% | 22Cr | |
-32.14% | 7.93Cr | |
+21.81% | 6.46Cr |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies Interim CEO Agrees to Resign; Mandel Steps in as Interim CEO